Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient Registry
Authors:
Open Access
- 16 December 2015
- journal article
- research article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 3 (2) , 130-138
Abstract
Background: Cervical dystonia is thought to result in high disease burden, but limited information exists on its impact on employment and work productivity. We utilized data from the Cervical Dystonia Patient Registry for the Observation of OnabotulinumtoxinA Efficacy (ClinicalTrials.gov identifier: NCT 00836017) to assess the impact of cervical dystonia on employment and work productivity and examine the effect of onabotulinumtoxinA treatments on work productivity. Methods: Subjects completed a questionnaire on employment status and work productivity at baseline and final visit. Baseline data were examined by severity of cervical dystonia, predominant subtype, presence of pain, prior exposure to botulinum toxin, and/or utility of a sensory trick. Work productivity results at baseline and final visit were compared in subjects who were toxin‐naïve at baseline and received three onabotulinumtoxinA treatments. Results: Of 1,038 subjects, 42.8% were employed full‐ or part‐time, 6.1% unemployed, 32.7% retired, and 11.8% disabled. Of those currently employed, cervical dystonia affected work status of 26.0%, caused 29.8% to miss work in the past month (mean, 5.1 ± 6.4 days), and 57.8% reported decreased productivity. Half of those unemployed were employed when symptoms began, and 38.5% attributed lost employment to cervical dystonia. Pain, increasing severity, and anterocollis/retrocollis had the largest effects on work status/productivity. Preliminary analyses showed that absenteeism and presenteeism were significantly decreased following onabotulinumtoxinA treatments in the subpopulation that was toxin‐naïve at baseline. Conclusions: This analysis confirms the substantial negative impact of cervical dystonia on employment, with cervical dystonia‐associated pain being a particularly important driver. OnabotulinumtoxinA treatment appears to improve work productivity.Keywords
Funding Information
- Allergan
This publication has 16 references indexed in Scilit:
- Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disordersToxicon, 2013
- Phenomenology and classification of dystonia: A consensus updateMovement Disorders, 2013
- Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesisThe Lancet Neurology, 2011
- Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment statusMovement Disorders, 2009
- Clinical comparison of tardive and idiopathic cervical dystoniaMovement Disorders, 1998
- Cervical dystoniaNeurology, 1991
- Spasmodic Torticollis — Review of 220 PatientsCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1991
- Idiopathic cervical dystonia: Clinical characteristicsMovement Disorders, 1991
- Natural History of Adult-Onset Idiopathic TorticollisArchives of Neurology, 1990
- Spontaneous remissions in spasmodic torticollisNeurology, 1986